Skip to content

Gender Dysphoria: Epidemiological Data

Epidemiological Characteristics of the Population of Persons With Gender Dysphoria : Data From the Cohort Follow-up in CHRU de Nancy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04573127
Acronym
DyGenEpi
Enrollment
320
Registered
2020-10-05
Start date
2020-07-27
Completion date
2021-11-30
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gender Dysphoria

Brief summary

Retrospective study in a single academic regional transgender referral center. data from the cohort follow-up in CHRU de Nancy

Interventions

Retrospective analysis of existing data collected as a part of the regular follow-up

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Retrospective analysis of available data as a part of the regular care of subjects with gender dysphoria. All measurements were made at the time of the routine follow-up visits

Design outcomes

Primary

MeasureTime frameDescription
Incdience rate of cardiovascular diseases2004-2020Number of new cases of arterial hypertension, stroke, myocardial infarction during the specified period (2004-2020) /Time each person was observed, totaled for all persons
Incidence rate of dyslipidemia2004-2020Number of new cases of dyslipidemia during the specified period (2004-2020) /Time each person was observed, totaled for all persons

Secondary

MeasureTime frameDescription
Incidence rate of oncological diseases2004-2020Number of new cases of malignancies during the specified period (2004-2020) /Time each person was observed, totaled for all persons
Incidence rate of psychiatric diseases2004-2020Number of new cases of psychiatric diseases malignancies during the specified period (2004-2020) /Time each person was observed, totaled for all persons
Overall mortality rate2004-2020Mortality during the specified period (2004-2020) /Time each person was observed, totaled for all persons

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026